...
首页> 外文期刊>Vaccine >Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge
【24h】

Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge

机译:重组H5血凝素均用纳米乳液施加,保护雪貂免受致病性禽流感病毒攻击

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Highly pathogenic H5N1 influenza viruses remain a pandemic risk to the world population. Although vaccines are the best solution to prevent this threat, a more effective vaccine for H5 strains of influenza has yet to be developed. All existing vaccines target only serum antibody against influenza as the primary outcome, while mucosal immunity has not been addressed. To address these shortcomings we have used an effective mucosal adjuvant system to produce a prototype vaccine that provides antibody, cellular and mucosal immunity to multiple serotypes of H5.
机译:背景:高病原H5N1流感病毒仍然是世界人口的大流行风险。 虽然疫苗是防止这种威胁的最佳解决方案,但尚未开发出更有效的血型流感菌株的疫苗。 所有现有的疫苗只针对血清抗体免受流感的主要结果,而粘膜免疫尚未得到解决。 为了解决这些缺点,我们使用了有效的粘膜佐剂系统来生产原型疫苗,为H5的多种血清型提供抗体,细胞和粘膜免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号